Investigating the Distribution: Signal, Noise, and the Resolution Toolkit in Evidence‐Based Medicine
- 1Department of Family Medicine Western University London Ontario Canada
Abstract
Rationale, Aims and Objectives: Evidence‐based medicine (EBM) manages observational noise but lacks an explicit framework for taxonomic blur: treatment‐relevant variation generated when syndromic populations mix patients differing in mechanism or treatment responsiveness. Patients present with syndromes, not resolved pathophysiological classes. This article identifies the epistemological gap between adjudicating average treatment effects and developing reference classes where effects are clinically meaningful. We define the Resolution Toolkit for taxonomic development, showing how statistical patterns, error detection and clinical investigation contribute without being mistaken for taxonomic proof.
Method: Conceptual analysis, historical exemplars (syphilis, AIDS), illustrative simulations, and instruments from philosophy of science and established statistical theory.
Results: The Resolution Toolkit comprises high‐resolution observation, rich trial designs (e.g., crossover where feasible), statistical instruments for pattern detection and clinical diagnostic reasoning. Simulations show: population effects vary markedly with the Mixing Ratio despite fixed large responder effects; a parallel randomised controlled trial (RCT) can sometimes yield Gaussian mixture model (GMM)/Bayesian information criterion (BIC) component structure without recovering the known responder class; and Hartigan's dip test can have limited power for genuinely bimodal mixtures at modest sample sizes. Posterior probabilities can enrich candidate responder sets for investigation, provided they are interpreted as case‐finding tools rather than biological mechanism probabilities.
Conclusion: Statistical methods reveal patterns and nominate informative patients, but neither positive nor negative results establish or exclude treatment‐relevant classes. Taxonomic development remains investigative: anomalies must be preserved, competing explanations eliminated and independent evidence brought into consilience. The Toolkit complements adjudicatory EBM by organising this work.
Related
- Biostatistics for Evidence-Based Medicine: A Practical Review for Clinicians.
- Sequince: a modular sequential Monte Carlo toolkit
- Computation-through-Dynamics Toolkit: Simulated datasets and quality metrics for dynamical models of neural activity
- Investigating the Teaching and Practice of Quantitative Methods in French and French-Speaking Belgian Archaeology
- Investigating the Early Signatures of Feature Learning in Deep Linear Networks
BibTeX
@article{arthur2026investigating,
title = {{Investigating the Distribution: Signal, Noise, and the Resolution Toolkit in Evidence‐Based Medicine}},
author = {Frederick Arthur},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
month = oct,
doi = {10.1111/jep.70551},
url = {https://doi.org/10.1111/jep.70551},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Investigating the Distribution: Signal, Noise, and the Resolution Toolkit in Evidence‐Based Medicine
AU - Frederick Arthur
PY - 2026
DA - 2026/10/28
JO - Journal of Evaluation in Clinical Practice
DO - 10.1111/jep.70551
UR - https://doi.org/10.1111/jep.70551
AB - Rationale, Aims and Objectives: Evidence‐based medicine (EBM) manages observational noise but lacks an explicit framework for taxonomic blur: treatment‐relevant variation generated when syndromic populations mix patients differing in mechanism or treatment responsiveness. Patients present with syndromes, not resolved pathophysiological classes. This article identifies the epistemological gap between adjudicating average treatment effects and developing reference classes where effects are clinically meaningful. We define the Resolution Toolkit for taxonomic development, showing how statistical patterns, error detection and clinical investigation contribute without being mistaken for taxonomic proof. Method: Conceptual analysis, historical exemplars (syphilis, AIDS), illustrative simulations, and instruments from philosophy of science and established statistical theory. Results: The Resolution Toolkit comprises high‐resolution observation, rich trial designs (e.g., crossover where feasible), statistical instruments for pattern detection and clinical diagnostic reasoning. Simulations show: population effects vary markedly with the Mixing Ratio despite fixed large responder effects; a parallel randomised controlled trial (RCT) can sometimes yield Gaussian mixture model (GMM)/Bayesian information criterion (BIC) component structure without recovering the known responder class; and Hartigan's dip test can have limited power for genuinely bimodal mixtures at modest sample sizes. Posterior probabilities can enrich candidate responder sets for investigation, provided they are interpreted as case‐finding tools rather than biological mechanism probabilities. Conclusion: Statistical methods reveal patterns and nominate informative patients, but neither positive nor negative results establish or exclude treatment‐relevant classes. Taxonomic development remains investigative: anomalies must be preserved, competing explanations eliminated and independent evidence brought into consilience. The Toolkit complements adjudicatory EBM by organising this work.
SN - 1356-1294
SN - 1365-2753
ER -